Company Overview

KP Tissue Inc. is a Canadian publicly traded company that holds an equity interest in Kruger Products Inc., one of Canada’s largest manufacturers and distributors of tissue products for consumer and commercial markets. The company operates within the household products and paper products industry, with revenue exposure tied primarily to tissue manufacturing, sales, and distribution across North America. KP Tissue’s economic performance is substantially linked to the operating results of Kruger Products Inc., which manufactures bathroom tissue, paper towels, facial tissue, and napkins under well-known brands including Cashmere, Purex, SpongeTowels, Scotties, and White Swan.

The company was established in 2012 as part of a reorganization involving Kruger Products L.P. and its parent entities. KP Tissue functions primarily as a holding entity whose principal asset is its ownership stake in Kruger Products Inc. The business has evolved through investments in manufacturing modernization, premium tissue products, and capacity expansion projects designed to strengthen its competitive position in the North American tissue market. Its strategic positioning benefits from established retail relationships, recognizable brands in Canada, and vertically integrated manufacturing capabilities.

Business Operations

KP Tissue generates value through its ownership interest in Kruger Products Inc., whose operations are organized across consumer and away-from-home tissue segments. The consumer business supplies retail tissue products to grocery, mass merchandise, warehouse club, and e-commerce channels, while the away-from-home segment serves commercial customers such as offices, hotels, restaurants, healthcare facilities, and institutions. Revenue is driven primarily by branded tissue sales, private label products, and commercial tissue supply agreements.

Operations are concentrated in Canada and the United States through multiple manufacturing facilities and distribution networks. Kruger Products Inc. controls tissue converting and production assets, including advanced paper machine technologies and integrated manufacturing operations. The company has invested in large-scale production facilities such as the Sherbrooke Expansion Project in Québec, which includes high-capacity tissue manufacturing and converting operations. The business also maintains strategic partnerships with retailers and distributors throughout North America and operates through subsidiaries associated with tissue manufacturing and product distribution activities.

Strategic Position & Investments

KP Tissue’s strategic direction is centered on long-term growth in branded tissue products, operational efficiency, and manufacturing scale expansion through Kruger Products Inc. Key initiatives have included investments in ultra-premium tissue production, automation, and supply chain optimization. A significant strategic investment has been the Sherbrooke Expansion Project, designed to increase production capacity and improve cost competitiveness in the North American market.

The company’s broader investment exposure includes continued support for innovation in sustainable tissue manufacturing, energy efficiency initiatives, and product premiumization. Through Kruger Products Inc., the organization participates in both consumer retail and institutional tissue sectors, providing diversification across customer channels. The business has also focused on strengthening relationships with major Canadian retailers and expanding U.S. market penetration, particularly in private label and commercial tissue categories.

Geographic Footprint

KP Tissue is headquartered in Mississauga, Ontario, Canada, while its principal operating exposure through Kruger Products Inc. spans both Canada and the United States. Manufacturing facilities and distribution operations are located across several Canadian provinces and U.S. regions, supporting nationwide retail and commercial distribution. The company maintains a particularly strong market presence in the Canadian consumer tissue sector through established household brands.

Its North American operational footprint includes production facilities in Québec, Ontario, British Columbia, and multiple U.S. jurisdictions. The organization’s products are distributed broadly through major retailers, wholesalers, institutional suppliers, and commercial channels. While the company’s core operations remain concentrated in North America, its supply chain and sourcing activities involve international procurement relationships tied to pulp, packaging, and manufacturing inputs.

Leadership & Governance

KP Tissue operates with a governance structure aligned closely with Kruger Products Inc., reflecting its role as a holding company with economic exposure to tissue manufacturing operations. The company’s leadership strategy has emphasized disciplined capital allocation, manufacturing modernization, brand development, and long-term shareholder value creation. Its governance framework includes oversight from executives with backgrounds in manufacturing, finance, consumer products, and industrial operations.

Key executives and leadership figures include:

• Dino Bianco – Chief Executive Officer
• Wayne Cheeseman – Chief Financial Officer
• Joseph Kruger II – Chairman
• Gordon Goss – Corporate Secretary
• Geneviève Gagnon – Senior executive leadership role within operations and corporate management

Public disclosures in SEC-equivalent Canadian securities filings, annual reports, management discussion and analysis documents, and investor materials consistently identify growth through operational scale, productivity improvements, and branded product leadership as central components of management’s strategic vision. Certain executive role details may vary over time based on updated public filings and corporate disclosures.